A Phase I/II Study Of PI-88 In Advanced Malignancies (Phase I), And In Advanced Melanoma(Phase II).
Phase of Trial: Phase I/II
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Muparfostat (Primary)
- Indications Cancer; Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 22 Apr 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 27 Sep 2005 New trial record.